ICLR
NASDAQ · Life Sciences Tools & Services
Icon Plc
$204.74
+3.09 (+1.53%)
Financial Highlights (FY 2026)
Revenue
7.80B
Net Income
216.88M
Gross Margin
26.4%
Profit Margin
2.8%
Rev Growth
+2.2%
D/E Ratio
0.37
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 26.4% | 26.4% | 48.1% | 48.1% |
| Operating Margin | 5.4% | 4.8% | 10.5% | 12.7% |
| Profit Margin | 2.8% | 2.6% | 7.4% | 7.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 7.80B | 7.64B | 3.35B | 2.67B |
| Gross Profit | 2.06B | 2.02B | 1.61B | 1.29B |
| Operating Income | 419.03M | 369.19M | 353.31M | 338.76M |
| Net Income | 216.88M | 191.09M | 247.00M | 186.41M |
| Gross Margin | 26.4% | 26.4% | 48.1% | 48.1% |
| Operating Margin | 5.4% | 4.8% | 10.5% | 12.7% |
| Profit Margin | 2.8% | 2.6% | 7.4% | 7.0% |
| Rev Growth | +2.2% | +2.2% | -1.3% | +12.6% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 2.07B | 2.07B | 6.18B | 4.84B |
| Total Equity | 5.58B | 5.58B | 4.58B | 4.76B |
| D/E Ratio | 0.37 | 0.37 | 1.35 | 1.02 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 781.00M | 726.33M | 599.26M | 448.41M |
| Free Cash Flow | — | — | 348.15M | 219.69M |